Janus Henderson Group plc Reports New 5.1% Stake in Bicara Therapeutics Inc. (BCAX)

On May 15, 2026, Janus Henderson Group plc filed a Schedule 13G reporting a new 5.1% stake in Bicara Therapeutics Inc. (BCAX). The filing indicates that Janus Henderson Group plc, as the ultimate parent company of several SEC-registered investment advisers, beneficially owns 3,339,218 shares of common stock. These shares were acquired in the ordinary course of business and are held through various managed portfolios, including investment companies and institutional separate accounts. The reporting person shares voting and dispositive power over the entire 3,339,218 share position. This filing follows an event date of March 31, 2026, marking a significant increase from a previously reported 0.0% ownership position. Janus Henderson Group plc disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, noting that the managed portfolios have the right to receive dividends and sales proceeds. No individual managed portfolio owns more than 5% of the issuer's outstanding common stock.